Dr. Wang graduated from Gunma University with his Ph.D. in the field of Molecular Medicine, Islet biology, and diabetes and did his Postdoc studies at the University of Chicago. He then went on to be an Assistant Professor at the Ohio State University where he worked in the Department of Internal Medicine in the Division of Endocrinology with a focus on Diabetes & Metabolism. While at Ohio State University, Dr. Wang was one of the key researchers in developing a novel methodology to study the early post-translational process of an insulin precursor.Before working with Viva Biotech, Dr. Wang was a Principal Scientist with Eli Lilly where he led projects focusing on protein and small molecule medicine for treatment of diabetes and/or NASH and brought 2 projects to the portfolio/pipeline.